Docetaxel (Taxotere) Outdoes Doxorubicin (Adriamycin)
SAN ANTONIO, Dec. 14 -- An adjuvant chemotherapy regimen that substitutes docetaxel (Taxotere) for doxorubicin (Adriamycin) is more effective in early breast cancer, seven-year follow-up of a randomized controlled trial showed.
To read full article: http://www.medpagetoday.com/MeetingC...eeting/tb/7689 |
All times are GMT -7. The time now is 10:57 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021